PRESS RELEASE published on 03/16/2026 at 21:30, 7 months 19 days ago Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity Zomedica reports record $10 million quarterly revenue, 20th consecutive year-over-year growth. Financial highlights and strategic outlook unveiled Growth Strategy Financial Results Revenue Growth Zomedica Animal Health
BRIEF published on 03/10/2026 at 11:35, 7 months 25 days ago Zomedica présentera ses résultats financiers pour 2025 et ses perspectives sur le marché équin. Webinaire Zomedica Résultats Financiers 2025 Marché Équin Solutions Vétérinaires
BRIEF published on 03/10/2026 at 11:35, 7 months 25 days ago Zomedica to Showcase 2025 Financials and Equine Market Insights Webinar Zomedica Equine Market 2025 Financial Results Veterinary Solutions
PRESS RELEASE published on 03/10/2026 at 11:30, 7 months 25 days ago Zomedica to Review 2025 Financial Results and Highlight Equine Market Opportunity During March 27th "Fourth Friday at Four" Investor Webinar Zomedica Corp. announces upcoming investor webinar to discuss full-year 2025 financial results, equine veterinary market insights, and product portfolio. Event to feature live Q&A session Zomedica Corp. Product Portfolio Investor Webinar 2025 Financial Results Equine Veterinary Market
BRIEF published on 02/25/2026 at 12:35, 8 months 7 days ago Zomedica and Moichor Collaborate on TRUVIEW Digital Microscopy Distribution AI Integration Zomedica Veterinary Diagnostics TRUVIEW Moichor
BRIEF published on 02/25/2026 at 12:35, 8 months 7 days ago Zomedica et Moichor collaborent à la distribution du microscope numérique TRUVIEW Zomedica Intégration De L'IA Diagnostic Vétérinaire TRUVIEW Moichor
PRESS RELEASE published on 02/25/2026 at 12:30, 8 months 7 days ago Zomedica Expands Distribution of TRUVIEW(R) Digital Microscopy Platform Through National Agreement with Moichor, a Leader in Veterinary Pathology Zomedica Corp. partners with Moichor to expand access to TRUVIEW digital microscopy systems in veterinary practices, enhancing diagnostic capabilities and supporting recurring revenue growth Zomedica Corp. Veterinary TRUVIEW Moichor Digital Microscopy
BRIEF published on 02/05/2026 at 12:35, 8 months 27 days ago Zomedica organise un webinaire en février sur la R&D et l'innovation Innovation Webinaire Zomedica Santé Animale Stratégie De R&D
BRIEF published on 02/05/2026 at 12:35, 8 months 27 days ago Zomedica Schedules February Webinar on R&D and Innovation Innovation Webinar Zomedica Animal Health R&D Strategy
PRESS RELEASE published on 02/05/2026 at 12:30, 8 months 27 days ago Zomedica Announces "Fourth Friday at Four" Webinar on February 27th Focused on Research & Development and Its Innovation Pipeline Zomedica's R&D strategy for scalable growth and long-term shareholder value highlighted in Fourth Friday at Four investor webinar on February 27, 2026, 4:00 p.m. ET Zomedica Investor Webinar R&D Strategy Long-term Value Scalable Growth
Published on 11/04/2026 at 23:10, 3 hours 49 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 3 hours 59 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 4 hours 44 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 4 hours 54 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 00:02, 2 hours 57 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 19:41, 7 hours 18 minutes ago EQS-Adhoc: SNP SE Raises Outlook for the Full Year 2026
Published on 11/04/2026 at 19:25, 7 hours 34 minutes ago Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
Published on 11/04/2026 at 18:43, 8 hours 16 minutes ago EQS-Adhoc: Deutsche EuroShop refines its revenue forecast and raises its earnings forecast for the 2026 financial year
Published on 11/04/2026 at 18:05, 8 hours 54 minutes ago Redis Expands Redis Iris to Give AI Agents the Memory, Context, and Messaging They Need to get to Production
Published on 11/04/2026 at 18:00, 8 hours 59 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 8 hours 59 minutes ago L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:44, 9 hours 15 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026